Clinical trials: Oligohydramnios

Oligohydramnios

Hydrotherapy for the Reversal of Oligohydramnios

• Terminated
• Age: 18 years and older
• Pill or oral medicine
• Injection or infusion
• Results posted

OBJECTIVE: To assess the efficacy of subtotal immersion therapy as an option to improve maternal intravascular volume thereby improving both maternal and fetal hemodynamic status with reversal of oligohydramnios.

Trial name

STRONG (NCT01682928)

Testing

IV/Oral Hydration and Bedrest, Hydrotherapy

Where

United States

Volunteers

4 people

Sponsor

Pediatrix